Clinical Trial Update: Immunogenicity and Safety of Three Consecutive Lots of a New Inactivated Enterovirus Type 71 (EV71) Vaccine [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating immunogenicity and safety across three consecutive lots of an inactivated Enterovirus Type 71 vaccine for Hand, Foot and Mouth Diseas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hand Foot and Mouth Disease

Drugs mentioned

• EV71 inactivated vaccine (Enterovirus Type 71 vaccine (inactivated))

Snippet

Sponsor: Sinovac Biotech Co., Ltd | Conditions: Hand, Foot and Mouth Disease | Phase 3 | Status: COMPLETED